Home > Insider Trading > Filing (0001321732-20-000011)

Filing Details

Accession Number:: 0001321732-20-000011
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-01-29 20:10:30
Reporting Period:: 2020-01-27

Accepted Time:: 2020-01-29 20:10:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1321732	Penumbra Inc	PEN	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1704713	Bridget O'rourke	One Penumbra Place Alameda CA 94502		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-01-27	5	$169.07	3,069	No	4	S	Direct
Common Stock	Disposition	2020-01-27	3	$169.98	3,066	No	4	S	Direct
Common Stock	Disposition	2020-01-27	16	$171.54	3,050	No	4	S	Direct
Common Stock	Disposition	2020-01-27	96	$172.36	2,954	No	4	S	Direct
Common Stock	Disposition	2020-01-27	17	$173.11	2,937	No	4	S	Direct
Common Stock	Disposition	2020-01-27	26	$174.13	2,911	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
This transaction was executed in multiple trades at prices ranging from $168.79 to $169.26. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
A portion of these shares is subject to vesting.
This transaction was executed in multiple trades at prices ranging from $169.85 to $170.04. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $170.89 to $171.76. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $171.80 to $172.74. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $172.81 to $173.51. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $173.84 to $174.56. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.